Renaissance Capital logo

SPAC Heroic Empire Acquisition files for a $100 million IPO, targeting AI, biotech, energy, and manufacturing

October 27, 2026

Heroic Empire Acquisition, a blank check company targeting AI, biotech, energy, and advanced manufacturing, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

The Hong Kong, China-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one right to receive one-fourths of one ordinary share upon the consummation of an initial business combination.

Heroic Empire Acquisition is led by CEO and Chairman William Ip, the Managing Director of Amasse Capital, and CFO and Director Mitchell Cariaga, the President of Orange Grove Trading and General Partner of Citrus Grove Capital. The SPAC plans to target businesses in the artificial intelligence, biotechnology, TMT, new energy, and advanced manufacturing sectors in Asia and North America.

Heroic Empire Acquisition previously filed to raise $75 million in a Nasdaq IPO in February 2022, but withdrew its filing in December 2023.

The Hong Kong, China-based company was founded in 2021. It plans to list on the Nasdaq under the symbol HEACU.RC. Heroic Empire Acquisition filed confidentially on January 21, 2026. A.G.P. and Haitong International are the joint bookrunners on the deal.